 |
Butyrylcholinesterase |
|---|---|
| Trade Name | |
| Orphan Indication | For the reduction and clearance of toxic blood levels of cocaine encountered during a drug overdose |
| USA Market Approval | USA |
| USA Designation Date | 1992-03-25 00:00:00 |
| Sponsor | Shire Laboratories Inc.;1550 East Gude Drive;Rockville, Maryland, 20850 |
